{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:08:58Z","timestamp":1785240538171,"version":"3.55.0"},"reference-count":39,"publisher":"Veterinary World","issue":"8","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"am","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005286","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa\u00a0do Estado de\u00a0Mato Grosso","doi-asserted-by":"publisher","award":["37775.544.22074.23092016"],"award-info":[{"award-number":["37775.544.22074.23092016"]}],"id":[{"id":"10.13039\/501100005286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:p>Background and Aim: Canine visceral leishmaniasis (CanL) has a broad spectrum of changes, with kidney disease being considered the main cause of mortality. Thus, this study aimed to monitor serum and urinary biomarkers in response to two short-term treatments for CanL.\n\nMaterials and Methods: Thirty dogs with CanL were equally divided into two treatment groups and treated with either miltefosine (Group M) or miltefosine plus allopurinol (Group MA); the groups were evaluated before treatment and after 28 days of treatment. Physical exams were performed and hematimetric, biochemical, and urinary parameters, including urinary biomarkers cystatin C (CisC), lipocalin-2 (NGAL), and microalbuminuria, were measured.\n\nResults: Both treatments significantly reduced clinical scores (p&lt;0.05), but only the MA group saw a reduction in the clinical-pathological score. The serum albumin and calcium levels increased significantly in the MA and M groups (p&lt;0.05). Proteinuria and urinary density did not decrease significantly after the treatments. With regard to the biomarkers, CisC and microalbuminuria did not have any significant changes; however, NGAL was significantly reduced in the MA group (p&lt;0.05).\n\nConclusion: Both pharmacotherapeutic protocols promoted clinical and clinical-pathological improvements. In addition, miltefosine plus allopurinol proved to be a safe treatment due to the lack of changes detected in the monitored renal biomarkers. The treatment with miltefosine plus allopurinol proved to be the most effective, with more pronounced beneficial effects for canines with visceral leishmaniasis.<\/jats:p>","DOI":"10.14202\/vetworld.2020.1620-1626","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T07:02:08Z","timestamp":1597734128000},"page":"1620-1626","source":"Crossref","is-referenced-by-count":17,"title":["Monitoring of serum and urinary biomarkers during treatment of canine visceral leishmaniasis"],"prefix":"10.14202","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8303-6302","authenticated-orcid":false,"given":"Alvaro Felipe de Lima Ruy","family":"Dias","sequence":"first","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-5325","authenticated-orcid":false,"given":"Eveline da Cruz Boa Sorte","family":"Ayres","sequence":"additional","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1847-7574","authenticated-orcid":false,"given":"Fernanda Harumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3168-7944","authenticated-orcid":false,"given":"Bruna Ribeiro Gomes","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-4959","authenticated-orcid":false,"given":"Maria Sabrina","family":"de Freitas","sequence":"additional","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-1407","authenticated-orcid":false,"given":"Arleana do Bom Parto Ferreira","family":"de Almeida","sequence":"additional","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9367-5028","authenticated-orcid":false,"given":"Adriane Jorge","family":"Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Pathology Laboratory, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6209-4514","authenticated-orcid":false,"given":"Val\u00e9ria R\u00e9gia Franco","family":"Sousa","sequence":"additional","affiliation":[{"name":"Program of Postgraduate in Veterinary Sciences, Faculty of Veterinary Medicine, Federal University of Mato Grosso, Cuiab\u00e1 - MT, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5308","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"ref0","unstructured":"Marcondes, M. and Day, M.J. (2019) Current status and management of canine leishmaniasis in Latin America. Res. Vet. Sci., 123  : 261-272."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Sousa, V.R.F., Dias, A.F.L., Rodrigues, J.Y., Torres, M.M., Moreira, J.M.A., Nakazato, L., Dutra, V. and Almeida, A.B.P. (2019) Canine visceral leishmaniasis in riverside communities of the Cuiab\u00e1 river watershed. Semin. Ci\u00eanc. Agr\u00e1r., 40(6): 1-8.","DOI":"10.5433\/1679-0359.2019v40n6supl2p3313"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Solano-Gallego, L., Mir\u00f3, G., Koutinas, A., Cardoso, L., Pennisi, M.G., Ferrer, L., Bourdeau, P., Oliva, G. and Baneth, G. (2011) LeishVet guidelines for practical management of canine leishmaniosis. Parasit. Vectors, 4(86  ): 1-16.","DOI":"10.1186\/1756-3305-4-86"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Ribeiro, R.R., Michalick, M.S.M., Silva, M.E., Dos Santos, C.C.P., Fr\u00e9zard, F.J.G. and Silva, S.M. (2018) Canine leishmaniasis: An overview of the current status and strategies for control. Biomed Res. Int., 2018, Article ID 3296893  , pages 1-12.","DOI":"10.1155\/2018\/3296893"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Mel\u00e9ndez-Lazo, A., Ordeix, L., Planellas, M., Pastor, J. and Solano-Gallego, L. (2018) Clinicopathological findings in sick dogs naturally infected with Leishmania infantum: Comparison of five different clinical classification systems. Res. Vet. Sci., 117  : 18-27.","DOI":"10.1016\/j.rvsc.2017.10.011"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Junior, G.B.S., Barros, E.J.G. and Daher, E.F. (2014) Kidney involvement in leishmaniasis a review. Braz. J. Infect. Dis., 18(4): 434-440.","DOI":"10.1016\/j.bjid.2013.11.013"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Dayakar, A., Chandrasekaran, S., Kuchipudi, S.V. and Kalangi, S.K. (2019) Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: Opportunities for novel diagnostics and immunotherapy. Front. Immunol., 10  : 670.","DOI":"10.3389\/fimmu.2019.00670"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Zatelli, A., Borgarelli, M., Santilli, R., Bonfanti, U., Nigrisoli, E., Zanatta, R., Tarducci, A. and Guarraci, A. (2003) Glomerular lesions in dogs infected with Leishmania organisms. Am. J. Vet. Res., 64(5): 558-561.","DOI":"10.2460\/ajvr.2003.64.558"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Koutinas, A.F. and Koutinas, C.K. (2014) Pathologic mechanisms underlying the clinical findings in canine leishmaniosis due to Leishmania infantum\/chagasi. Vet. Pathol., 51(2): 527-538.","DOI":"10.1177\/0300985814521248"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Paltrinieri, S., Gradoni, L., Roura, X., Zatelli, A. and Zini, E. (2016) Laboratory tests for diagnosing and monitoring canine leishmaniasis. Vet. Clin. Pathol., 45(4): 552-578.","DOI":"10.1111\/vcp.12413"},{"key":"ref10","unstructured":"Iris. (2019) IRIS Guidelines. Available from: http:\/\/www.iris-kidney.com\/guidelines\/staging.html. Retrieved on 12-11-2019."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Hokamp, J.A. and Nabity, M.B. (2016) Renal biomarkers in domestic species. Vet. Clin. Pathol., 45(1): 28-56.","DOI":"10.1111\/vcp.12333"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Cobrin, A.R., Blois, S.L., Kruth, S.A., Abrams-Ogg, A.C. and Dewey, C. (2013) Biomarkers in the assessment of acute and chronic kidney diseases in the dog and cat. J. Small Anim. Pract., 54(12): 647-655.","DOI":"10.1111\/jsap.12150"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kovarikova, S. (2015) Urinary biomarkers of renal function in dogs and cats: A review. Vet. Med., 60(11): 589-602.","DOI":"10.17221\/8527-vetmed"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Mir\u00f3, G., G\u00e1lvez, R., Fraile, C., Descalzo, M.A. and Molina, R. (2011) Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. Parasit. Vectors, 4  : 52.","DOI":"10.1186\/1756-3305-4-52"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Bruno, B., Romano, A., Zanatta, R., Spina, S., Mignone, W., Ingravalle, F., Barzanti, P., Ceccarelli, L. and Goria, M. (2019) Serum indirect immunofluorescence assay and real-time PCR results in dogs affected by Leishmania infantum: Evaluation before and after treatment at different clinical stages. J. Vet. Diagn. Invest., 31(2): 222-227.","DOI":"10.1177\/1040638718824140"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Lachaud, L., Marchergui-Hammami, S., Chabbert, E., Dereure, J., Dedet, J.P. and Bastien, P. (2002) Comparison of six PCR methods using peripheral blood for detection on canine visceral leishmaniasis. J. Clin. Microbiol., 40(1): 210-215.","DOI":"10.1128\/jcm.40.1.210-215.2002"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Almeida, A.B.P., Sousa, V.R.F., Gasparetto, N.D., Silva, G.F.R., Figueiredo, F.B., Dutra, V., Nakazato, L. and Madeira, M.F. (2013) Canine visceral leishmaniasis: Diagnostic approaches based on polymerase chain reaction employing different biological samples. Diagn. Microbiol. Infect. Dis., 76(1): 321-324.","DOI":"10.1016\/j.diagmicrobio.2013.03.017"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Murgier, P., Jakins, A., Bexfield, N. and Archer, J. (2009) Comparison of semiquantitative test strips, urine protein electrophoresis, and immunoturbidimetric assay for measuring microalbuminuria in dogs. Vet. Clin. Pathol., 38(4): 485-492.","DOI":"10.1111\/j.1939-165x.2009.00176.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Manna, L., Corso, R., Galiero, L., Cerrone, A., Muzj, P. and Gravino, A.E. (2015) Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Parasit. Vectors, 8  : 289.","DOI":"10.1186\/s13071-015-0896-0"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Tafuri, W.L., Michalick, M.S.M., Dias, M., Genaro, O., Leite, V.H.R., Barbosa, A.J.A., Bambirra, E.A, Costa, A.A., Melo, M.N. and Mayrink, W. (1989) Estudo, ao microsc\u00f3pio \u00f3ptico e eletr\u00f4nico, do rim de c\u00e3es natural e experimentalmente infectados com Leishmania (Leishmania) chagasi. Rev. Inst. Med. Trop. S\u00e3o Paulo., 31(3): 139-145.","DOI":"10.1590\/s0036-46651989000300002"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"de Yb\u00e1\u00f1ez, R.R., Del R\u00edo, L., Mart\u00ednez-Carrasco, C., Segovia, M., Cox, J., Davies, C. and Berriatua, E. (2009) Questionnaire survey on canine leishmaniosis in Southeastern Spain. Vet. Parasitol., 164(1): 124-133.","DOI":"10.1016\/j.vetpar.2009.06.013"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Pineda, C., Aguilera-Tejero, E., Morales, M.C., Belinchon-Lorenzo, S., Gomez-Nieto, L.C., Garcia, P., Martinez-Moreno, J.M., Rodriguez-Ortiz, M.E. and Lopes, I. (2017) Treatment of canine leishmaniasis with marbofloxacin in dogs with renal disease. PLoS One., 12(10): e0185981.","DOI":"10.1371\/journal.pone.0185981"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Clementi, A., Battaglia, G., Floris, M., Castellino, P., Ronco, C. and Cruz, D.N. (2011) Renal involvement in leishmaniasis: A review of the literature. NDT Plus, 4(3): 147-152.","DOI":"10.1093\/ndtplus\/sfr008"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Rigo, R.S., Carvalho, C.M., Honer, M.R., Andrade, G.B., Silva, I.S., Rigo, L., Figueiredo, H.R. and Barreto, W.T. (2013) Renal histopathological findings in dogs with visceral leishmaniasis. Rev. Inst. Med. Trop. S\u00e3o Paulo., 55(2): 113-116.","DOI":"10.1590\/s0036-46652013000200008"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez, M.A.D., Mir\u00f3, G., Rodr\u00edguez, M.F., Noguer, C.R. and Arnold, C.F. (2019) Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis. Res. Vet. Sci., 126  : 131-138.","DOI":"10.1016\/j.rvsc.2019.08.026"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Bianciardi, P., Brovida, C., Valente, M., Aresu, L., Cavicchioli, L., Vischer, C., Giroud, L. and Castagnaro, M. (2009) Administration of miltefosine and meglumine antimoniate in healthy dogs: Clinicopathological evaluation of the impact on the kidneys. Toxicol. Pathol., 37(6): 770-775.","DOI":"10.1177\/0192623309344088"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Mir\u00f3, G., Oliva, G., Cruz, I., Ca\u00f1avate, C., Mortarino, M., Vischer, C. and Bianciardi, P. (2009) Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet. Dermatol., 20(5-6): 397-404.","DOI":"10.1111\/j.1365-3164.2009.00824.x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Nogueira, F.D.S., Avino, V.C., Galvis-Ovallos, F., Pereira-Chioccola, V.L., Moreira, M.A.B., Romariz, A.P.P., Mola, L.M. and Menz I. (2019) Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil. Parasit. Vectors, 12  : 79.","DOI":"10.1186\/s13071-019-3323-0"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Pardo-Mar\u00edn, L., Mart\u00ednez-Subiela, S., Pastor, J. Tvarijonaviciute, A., Garcia-Martinez, J.D., Segarra, S. and Joaqu\u00edn, J. (2016) Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment. BMC Vet. Res., 13(31  ): 1-7.","DOI":"10.1186\/s12917-017-0956-0"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"De Loor, D.S., Daminet, S., Smets, P., Maddens, B. and Meyer, E. (2013) Urinary biomarkers of acute kidney injury in dogs. J. Vet. Intern. Med., 27(5): 998-1010.","DOI":"10.1111\/jvim.12155"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Palacio, J., Liste, F. and Gasc\u00f3n, M. (1995) Urinary protein\/creatinine ratio in the evaluation of renal failure in canine leishmaniasis. Vet. Rec., 137(22): 567-568.","DOI":"10.1136\/vr.137.22.567"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Proverbio, D., Spada, E., Giorgi, G.B. and Perego, R. (2016) Proteinuria reduction after treatment with miltefosine and allopurinol in dogs naturally infected with leishmaniasis. Vet. World., 9(8): 904-908.","DOI":"10.14202\/vetworld.2016.904-908"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Pressler, B.M. (2015) Clinical approach to advanced renal function testing in dogs and cats. Vet. Clin. North Am. Small Anim. Pract., 35(3): 487-502.","DOI":"10.1016\/j.cll.2015.05.001"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Tenstad, O., Roald, A.B., Grubb, A. and Aukland, K. (1996) Renal handling of radiolabelled human cystatin C in the rat. Scand. J. Clin. Lab. Invest., 56(5): 409-414.","DOI":"10.3109\/00365519609088795"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Kaseda, R., Iino, N., Hosojima, M., Takeda, T., Hosaka, K., Kobayashi, A., Suzuki, A., Kasai, A., Suzuki, Y., Gejyo, F. and Saito, A. (2007) Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochem. Biophys. Res. Commun., 357(4): 1130-1134.","DOI":"10.1016\/j.bbrc.2007.04.072"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Mart\u00ednez, J.D., Martinez-Subiela, S., Tvarijonaviciute, A., Caldin, M. and Ceron, J.J. (2015) Urinary ferritin and cystatin C concentrations at different stages of kidney disease in leishmaniotic dogs. Res. Vet. Sci., 99  : 204-207.","DOI":"10.1016\/j.rvsc.2015.01.002"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Lee, Y.J., Hu, Y.Y., Lin, Y.S., Chang, C.T., Lin, F.Y., Wong, M.L. and Hsu, W.L. (2012) Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury. BMC Vet. Res., 8(248  ): 1-9.","DOI":"10.1186\/1746-6148-8-248"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Hsu, W.L., Chiou, H.C., Tung, K.C., Belot, G., Virilli, A., Wong, M.L. and Lee, Y.J. (2014) The different molecular forms of urine neutrophil gelatinase-associated lipocalin present in dogs with urinary diseases. BMC Vet. Res., 10(202  ): 1-8.","DOI":"10.1186\/s12917-014-0202-y"}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/August-2020\/19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/August-2020\/19.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/August-2020\/19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T12:05:34Z","timestamp":1606737934000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/August-2020\/19.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":39,"issue-title":["August-2020"],"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,6]]},"published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14202\/vetworld.2020.1620-1626","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"value":"2231-0916","type":"electronic"},{"value":"0972-8988","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}